DE3071942D1 - Method for the determination of antigens and antibodies using site-deactivating media - Google Patents

Method for the determination of antigens and antibodies using site-deactivating media

Info

Publication number
DE3071942D1
DE3071942D1 DE8080303940T DE3071942T DE3071942D1 DE 3071942 D1 DE3071942 D1 DE 3071942D1 DE 8080303940 T DE8080303940 T DE 8080303940T DE 3071942 T DE3071942 T DE 3071942T DE 3071942 D1 DE3071942 D1 DE 3071942D1
Authority
DE
Germany
Prior art keywords
sample
antigen
site
antibody reaction
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080303940T
Other languages
English (en)
Inventor
Robert Lee Stout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOME OFFICE REFERENCE LAB Inc
Original Assignee
HOME OFFICE REFERENCE LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOME OFFICE REFERENCE LAB Inc filed Critical HOME OFFICE REFERENCE LAB Inc
Application granted granted Critical
Publication of DE3071942D1 publication Critical patent/DE3071942D1/de
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
DE8080303940T 1980-11-05 1980-11-05 Method for the determination of antigens and antibodies using site-deactivating media Expired DE3071942D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP80303940A EP0051096B1 (de) 1980-11-05 1980-11-05 Verfahren zum Nachweis von Antigenen und Antikörpern unter Verwendung von Oberflächen entaktivierenden Mitteln

Publications (1)

Publication Number Publication Date
DE3071942D1 true DE3071942D1 (en) 1987-05-07

Family

ID=8187290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080303940T Expired DE3071942D1 (en) 1980-11-05 1980-11-05 Method for the determination of antigens and antibodies using site-deactivating media

Country Status (3)

Country Link
EP (1) EP0051096B1 (de)
AT (1) ATE26346T1 (de)
DE (1) DE3071942D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165162A (ja) * 1984-09-05 1986-04-03 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体を用いた免疫学的測定方法における非特異反応吸収剤
WO1986002733A1 (en) * 1984-10-31 1986-05-09 Alcon Laboratories, Incorporated Sandwich immunoassay of antigens involved in ophthalmic disorders
GB9515855D0 (en) * 1995-08-02 1995-10-04 Centocor U K Limited A specimen dilution indicator system for use in clinical diagnostic assays
CN110240576B (zh) * 2019-06-27 2023-04-21 广东达元绿洲食品安全科技股份有限公司 氢***半抗原和人工抗原及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US4190496A (en) * 1971-05-14 1980-02-26 Syva Company Homogeneous enzyme assay for antibodies
US3904367A (en) * 1973-08-15 1975-09-09 Gen Electric Contrast enhancement for immunological film detection
JPS5816471B2 (ja) * 1977-11-29 1983-03-31 持田製薬株式会社 免疫化学的測定試薬の安定化剤
GB2027031A (en) * 1978-08-02 1980-02-13 Hoffmann La Roche Diagnostic Reagent Comprising a Proteinaceous Material Bonded to a Latex

Also Published As

Publication number Publication date
EP0051096A1 (de) 1982-05-12
ATE26346T1 (de) 1987-04-15
EP0051096B1 (de) 1987-04-01

Similar Documents

Publication Publication Date Title
DK343679A (da) Immunologisk fremgangsmaade til bestemmelse af et immunkompleks i en vaeske samt det ved frmegangsmaaden anvendte diagnostiske middel
FI905282A0 (fi) Anordning och foerfarande foer snabb kvalitativ och kvantitativ bestaemning av naervaron av en reaktiv ligand i ett fluidum.
NO159820C (no) Fremgangsmaate ved bestemmelse av antigen-antistoff-reaksjoner.
ATE73690T1 (de) Teilchentrennungsverfahren.
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
SE8102558L (sv) Immunologisk bestemmningsmetod
AU2706384A (en) Colorimetric immunoassay on solid surface
SE8304145D0 (sv) Antigenanalysmetod och set
EP0113075A3 (de) Tragbares Immunoassay-Reaktionssystem, Verfahren zur Diagnose durch eine Immunbestimmung und Sonde oder Träger zur Durchführung des Verfahrens
KR910001379A (ko) 핵산 결정 방법
FI875210A (fi) Foerfarande och testanordning foer paovisning av ett aemne i ett prov.
DE3071942D1 (en) Method for the determination of antigens and antibodies using site-deactivating media
DE3471661D1 (en) Toxins and antibodies of c. difficile
DK366587A (da) Fremgangsmaade til bestemmelse af creatinkinase-mb
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
FR2577676B1 (fr) Procede de dosage immunologique des amines, anticorps monoclonaux et ensemble de reactifs pour la mise en oeuvre du procede
DK159297C (da) Fremgangsmaade til immunokemisk bestemmelse af hepatitis b kerneantigener og forsoegsudstyr og immunokemisk reagens til brug ved denne fremgangsmaade
DK0408542T3 (da) Fremgangsmåde til bestemmelse af antigener og/eller antistoffer i humane legemsvæsker samt test-kit til udøvelse af fremgangsmåden
AU1567688A (en) Method for the quantitative determination of serum proteins in body fluids and agents for carrying out the process
Nygren et al. Diffusion-in-gel enzyme-linked immunosorbent assay (DIG-ELISA). Quantification of antigen by diffusion over an antibody-coated surface
RU94006938A (ru) Способ твердофазного люминесцентного иммуноанализа компонентов биологических жидкостей
EP0389929A3 (de) Verfahren zur Bestimmung von Zelloberflächen-Antigen durch ein komplexes Antigen-Antikörper-Reaktionssystem und in diesem Verfahren verwendeter Apparat zur Fixierung von Immunozyten
FR2689246B1 (fr) Procede immunochimique de detection de l'origine d'une substance produite par genie genetique et reactifs pour sa mise en óoeuvre.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee